Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Parkinson's Disease

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 279 articles:
HTML format



Single Articles


    January 2020
  1. JEON N, Bortolato M
    What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson's disease? A preliminary pharmacoepidemiologic study.
    PLoS One. 2020;15:e0227128.
    PubMed     Abstract available


  2. YAFFE JA, Zlotnik Y, Ifergane G, Levy-Tzedek S, et al
    Implicit task switching in Parkinson's disease is preserved when on medication.
    PLoS One. 2020;15:e0227555.
    PubMed     Abstract available


  3. KAWASAKI T, Mikami K, Kamo T, Aoki R, et al
    Correction: Motor planning error in Parkinson's disease and its clinical correlates.
    PLoS One. 2020;15:e0228698.
    PubMed     Abstract available


  4. SHIIBA T, Arimura Y, Nagano M, Takahashi T, et al
    Improvement of classification performance of Parkinson's disease using shape features for machine learning on dopamine transporter single photon emission computed tomography.
    PLoS One. 2020;15:e0228289.
    PubMed     Abstract available


  5. GERA A, O'Keefe JA, Ouyang B, Liu Y, et al
    Gait asymmetry in glucocerebrosidase mutation carriers with Parkinson's disease.
    PLoS One. 2020;15:e0226494.
    PubMed     Abstract available



  6. Retraction: DJ-1 Modulates alpha-Synuclein Aggregation State in a Cellular Model of Oxidative Stress: Relevance for Parkinson's Disease and Involvement of HSP70.
    PLoS One. 2020;15:e0219023.
    PubMed    


  7. JEONG YJ, Jeong JE, Cheon SM, Yoon BA, et al
    Relationship between the washout rate of I-123 MIBG scans and autonomic function in Parkinson's disease.
    PLoS One. 2020;15:e0229860.
    PubMed     Abstract available


  8. URSINO M, Magosso E, Lopane G, Calandra-Buonaura G, et al
    Mathematical modeling and parameter estimation of levodopa motor response in patients with parkinson disease.
    PLoS One. 2020;15:e0229729.
    PubMed     Abstract available


  9. LIMA DP, de Almeida SB, Bonfadini JC, de Luna JRG, et al
    Clinical correlates of sarcopenia and falls in Parkinson's disease.
    PLoS One. 2020;15:e0227238.
    PubMed     Abstract available


  10. LEE J, Lee AL, Park JH, Moon JE, et al
    The clinical application of nigrosome 1 detection on high-resolution susceptibility-weighted imaging in the evaluation of suspected Parkinsonism: The real-world performance and pitfalls.
    PLoS One. 2020;15:e0231010.
    PubMed     Abstract available



  11. Expression of Concern: Mucuna pruriens (Velvet bean) Rescues Motor, Olfactory, Mitochondrial and Synaptic Impairment in PINK1B9 Drosophila melanogaster Genetic Model of Parkinson's Disease.
    PLoS One. 2020;15:e0231371.
    PubMed    


  12. BECK EN, Wang MTY, Intzandt BN, Almeida QJ, et al
    Sensory focused exercise improves anxiety in Parkinson's disease: A randomized controlled trial.
    PLoS One. 2020;15:e0230803.
    PubMed     Abstract available


  13. EMELYANOV A, Shtam T, Kamyshinsky R, Garaeva L, et al
    Cryo-electron microscopy of extracellular vesicles from cerebrospinal fluid.
    PLoS One. 2020;15:e0227949.
    PubMed     Abstract available


  14. SUZUKI M, Arai M, Hayashi A, Ogino M, et al
    Adherence to treatment guideline recommendations for Parkinson's disease in Japan: A longitudinal analysis of a nationwide medical claims database between 2008 and 2016.
    PLoS One. 2020;15:e0230213.
    PubMed     Abstract available


  15. LENNAERTS-KATS H, van der Steen JT, Vijftigschild Z, Steppe M, et al
    RADPAC-PD: A tool to support healthcare professionals in timely identifying palliative care needs of people with Parkinson's disease.
    PLoS One. 2020;15:e0230611.
    PubMed     Abstract available


  16. MULCAHY G, Atwood B, Kuznetsov A
    Basal ganglia role in learning rewarded actions and executing previously learned choices: Healthy and diseased states.
    PLoS One. 2020;15:e0228081.
    PubMed     Abstract available


  17. METZGER JM, Matsoff HN, Zinnen AD, Fleddermann RA, et al
    Post mortem evaluation of inflammation, oxidative stress, and PPARgamma activation in a nonhuman primate model of cardiac sympathetic neurodegeneration.
    PLoS One. 2020;15:e0226999.
    PubMed     Abstract available


  18. OVEISGHARAN S, Dawe RJ, Leurgans SE, Yu L, et al
    Total daily physical activity, brain pathologies, and parkinsonism in older adults.
    PLoS One. 2020;15:e0232404.
    PubMed     Abstract available


  19. WU W, Sung CC, Yu P, Li J, et al
    S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson's disease.
    PLoS One. 2020;15:e0232019.
    PubMed     Abstract available


  20. GIANNAKAKIS E, Hutchings F, Papasavvas CA, Han CE, et al
    Computational modelling of the long-term effects of brain stimulation on the local and global structural connectivity of epileptic patients.
    PLoS One. 2020;15:e0221380.
    PubMed     Abstract available


  21. SANCHEZ-LANZAS R, Castano JG
    Correction: Inhibitors of lysosomal function or serum starvation in control or LAMP2 deficient cells do not modify the cellular levels of Parkinson disease-associated DJ-1/PARK 7 protein.
    PLoS One. 2020;15:e0233091.
    PubMed     Abstract available


  22. GRUBER MT, Witte OW, Grosskreutz J, Prell T, et al
    Association between malnutrition, clinical parameters and health-related quality of life in elderly hospitalized patients with Parkinson's disease: A cross-sectional study.
    PLoS One. 2020;15:e0232764.
    PubMed     Abstract available


  23. KRISHNAGOPAL S, Coelln RV, Shulman LM, Girvan M, et al
    Identifying and predicting Parkinson's disease subtypes through trajectory clustering via bipartite networks.
    PLoS One. 2020;15:e0233296.
    PubMed     Abstract available


  24. WU W, Sung CC, Yu P, Li J, et al
    Correction: S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson's disease.
    PLoS One. 2020;15:e0235296.
    PubMed     Abstract available


  25. KUMSA A, Agenagnew L, Alemu B, Girma S, et al
    Psychotropic medications induced parkinsonism and akathisia in people attending follow-up treatment at Jimma Medical Center, Psychiatry Clinic.
    PLoS One. 2020;15:e0235365.
    PubMed     Abstract available


  26. REEDIJK M, Huss A, Verheij RA, Peeters PH, et al
    Parkinson's disease case ascertainment in prospective cohort studies through combining multiple health information resources.
    PLoS One. 2020;15:e0234845.
    PubMed     Abstract available


    January 2019

  27. Correction: Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes.
    PLoS One. 2019;14:e0210931.
    PubMed     Abstract available


  28. TESSA C, Toschi N, Orsolini S, Valenza G, et al
    Central modulation of parasympathetic outflow is impaired in de novo Parkinson's disease patients.
    PLoS One. 2019;14:e0210324.
    PubMed     Abstract available


  29. HARDING Z, Wilkinson T, Stevenson A, Horrocks S, et al
    Identifying Parkinson's disease and parkinsonism cases using routinely collected healthcare data: A systematic review.
    PLoS One. 2019;14:e0198736.
    PubMed     Abstract available


  30. LANG KC, Hackney ME, Ting LH, McKay JL, et al
    Antagonist muscle activity during reactive balance responses is elevated in Parkinson's disease and in balance impairment.
    PLoS One. 2019;14:e0211137.
    PubMed     Abstract available


  31. CANARIO N, Sousa M, Moreira F, Duarte IC, et al
    Impulsivity across reactive, proactive and cognitive domains in Parkinson's disease on dopaminergic medication: Evidence for multiple domain impairment.
    PLoS One. 2019;14:e0210880.
    PubMed     Abstract available


  32. WON JH, Kim M, Park BY, Youn J, et al
    Effectiveness of imaging genetics analysis to explain degree of depression in Parkinson's disease.
    PLoS One. 2019;14:e0211699.
    PubMed     Abstract available


  33. RUI Z, Qingling C, Xinyue Z, Xin Z, et al
    The related factors of sleep benefit in Parkinson's disease: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0212951.
    PubMed     Abstract available


  34. FANG YJ, Tan CH, Tu SC, Liu CY, et al
    More than an "inverted-U"? An exploratory study of the association between the catechol-o-methyltransferase gene polymorphism and executive functions in Parkinson's disease.
    PLoS One. 2019;14:e0214146.
    PubMed     Abstract available


  35. KANG J, Derva D, Kwon DY, Wallraven C, et al
    Voluntary and spontaneous facial mimicry toward other's emotional expression in patients with Parkinson's disease.
    PLoS One. 2019;14:e0214957.
    PubMed     Abstract available


  36. ARMSTRONG MJ, Rastgardani T, Gagliardi AR, Marras C, et al
    Barriers and facilitators of communication about off periods in Parkinson's disease: Qualitative analysis of patient, carepartner, and physician Interviews.
    PLoS One. 2019;14:e0215384.
    PubMed     Abstract available


  37. NOVAK P, Pimentel Maldonado DA, Novak V
    Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study.
    PLoS One. 2019;14:e0214364.
    PubMed     Abstract available


  38. ZHONG R, Chen Q, Zhang X, Zhang X, et al
    Correction: The related factors of sleep benefit in Parkinson's disease: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0216524.
    PubMed     Abstract available


  39. CHO J, Lee YJ, Kim YH, Shin CM, et al
    Quantitative MRI evaluation of gastric motility in patients with Parkinson's disease: Correlation of dyspeptic symptoms with volumetry and motility indices.
    PLoS One. 2019;14:e0216396.
    PubMed     Abstract available


  40. FLORENCIO RB, da Nobrega AJS, Lima INDF, Gualdi LP, et al
    Chest wall volume and asynchrony in stroke and Parkinson's disease subjects: A case-control study.
    PLoS One. 2019;14:e0216641.
    PubMed     Abstract available


  41. KANG J, Derva D, Kwon DY, Wallraven C, et al
    Correction: Voluntary and spontaneous facial mimicry toward other's emotional expression in patients with Parkinson's disease.
    PLoS One. 2019;14:e0217715.
    PubMed     Abstract available


  42. IZZO VA, Donati MA, Ramat S, Primi C, et al
    Impulse control disorders in Parkinson's disease: A systematic review on the psychometric properties of the existing measures.
    PLoS One. 2019;14:e0217700.
    PubMed     Abstract available


  43. HOPE TR, Selnes P, Rektorova I, Anderkova L, et al
    Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease.
    PLoS One. 2019;14:e0217922.
    PubMed     Abstract available


  44. LEE GB, Woo H, Lee SY, Cheon SM, et al
    The burden of care and the understanding of disease in Parkinson's disease.
    PLoS One. 2019;14:e0217581.
    PubMed     Abstract available


  45. CHEN YY, Fan HC, Tung MC, Chang YK, et al
    The association between Parkinson's disease and temporomandibular disorder.
    PLoS One. 2019;14:e0217763.
    PubMed     Abstract available


  46. NUNES A, Silva G, Duque C, Januario C, et al
    Retinal texture biomarkers may help to discriminate between Alzheimer's, Parkinson's, and healthy controls.
    PLoS One. 2019;14:e0218826.
    PubMed     Abstract available


  47. YANG YR, Cheng SJ, Lee YJ, Liu YC, et al
    Cognitive and motor dual task gait training exerted specific training effects on dual task gait performance in individuals with Parkinson's disease: A randomized controlled pilot study.
    PLoS One. 2019;14:e0218180.
    PubMed     Abstract available


  48. LAN BL, Yeo JHW
    Comparison of computer-key-hold-time and alternating-finger-tapping tests for early-stage Parkinson's disease.
    PLoS One. 2019;14:e0219114.
    PubMed     Abstract available


  49. MIHAILA D, Donegan J, Barns S, LaRocca D, et al
    The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function.
    PLoS One. 2019;14:e0218252.
    PubMed     Abstract available


  50. CERESNAK SR, Pass RH, Dubin AM, Yang L, et al
    Validation of a novel automated signal analysis tool for ablation of Wolff-Parkinson-White Syndrome.
    PLoS One. 2019;14:e0217282.
    PubMed     Abstract available


  51. SAKAI R, Suzuki M, Ueyama M, Takeuchi T, et al
    E46K mutant alpha-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type alpha-synuclein in Drosophila models of Parkinson's disease.
    PLoS One. 2019;14:e0218261.
    PubMed     Abstract available


  52. POLYCHRONIS S, Dervenoulas G, Yousaf T, Niccolini F, et al
    Dysphagia is associated with presynaptic dopaminergic dysfunction and greater non-motor symptom burden in early drug-naive Parkinson's patients.
    PLoS One. 2019;14:e0214352.
    PubMed     Abstract available


  53. STEVENSON SA, Ciucci MR, Kelm-Nelson CA
    Intervention changes acoustic peak frequency and mesolimbic neurochemistry in the Pink1-/- rat model of Parkinson disease.
    PLoS One. 2019;14:e0220734.
    PubMed     Abstract available


  54. JANSSEN S, Heijs JJA, van der Meijs W, Nonnekes J, et al
    Validation of the Auditory Stroop Task to increase cognitive load in walking tasks in healthy elderly and persons with Parkinson's disease.
    PLoS One. 2019;14:e0220735.
    PubMed     Abstract available


  55. ISAACS BR, Trutti AC, Pelzer E, Tittgemeyer M, et al
    Cortico-basal white matter alterations occurring in Parkinson's disease.
    PLoS One. 2019;14:e0214343.
    PubMed     Abstract available


  56. CHOI JH, Kim HJ, Lee JY, Yoo D, et al
    Long-term effects of bilateral subthalamic nucleus stimulation on sleep in patients with Parkinson's disease.
    PLoS One. 2019;14:e0221219.
    PubMed     Abstract available


  57. SAKHARKAR MK, Kashmir Singh SK, Rajamanickam K, Mohamed Essa M, et al
    A systems biology approach towards the identification of candidate therapeutic genes and potential biomarkers for Parkinson's disease.
    PLoS One. 2019;14:e0220995.
    PubMed     Abstract available


  58. OWENS-WALTON C, Jakabek D, Power BD, Walterfang M, et al
    Increased functional connectivity of thalamic subdivisions in patients with Parkinson's disease.
    PLoS One. 2019;14:e0222002.
    PubMed     Abstract available


  59. VIKENE K, Skeie GO, Specht K
    Subjective judgments of rhythmic complexity in Parkinson's disease: Higher baseline, preserved relative ability, and modulated by tempo.
    PLoS One. 2019;14:e0221752.
    PubMed     Abstract available


  60. STEGEMOLLER EL, Zaman A, Uzochukwu J
    Repetitive finger movement and circle drawing in persons with Parkinson's disease.
    PLoS One. 2019;14:e0222862.
    PubMed     Abstract available


  61. BORDONI L, Gabbianelli R, Fedeli D, Fiorini D, et al
    Positive effect of an electrolyzed reduced water on gut permeability, fecal microbiota and liver in an animal model of Parkinson's disease.
    PLoS One. 2019;14:e0223238.
    PubMed     Abstract available


  62. TSATALI M, Overton PG, Vivas AB
    Self-reported and experimentally induced self-disgust is heightened in Parkinson's disease: Contribution of behavioural symptoms.
    PLoS One. 2019;14:e0223663.
    PubMed     Abstract available


  63. ZHU Y, Pu J, Chen Y, Zhang B, et al
    Decreased risk of Parkinson's disease in diabetic patients with thiazolidinediones therapy: An exploratory meta-analysis.
    PLoS One. 2019;14:e0224236.
    PubMed     Abstract available


  64. LEI C, Sunzi K, Dai F, Liu X, et al
    Effects of virtual reality rehabilitation training on gait and balance in patients with Parkinson's disease: A systematic review.
    PLoS One. 2019;14:e0224819.
    PubMed     Abstract available


  65. SATO K, Nagashima Y, Mano T, Iwata A, et al
    Quantifying normal and parkinsonian gait features from home movies: Practical application of a deep learning-based 2D pose estimator.
    PLoS One. 2019;14:e0223549.
    PubMed     Abstract available


  66. PINKHARDT EH, Liu H, Ma D, Chen J, et al
    Olfactory screening of Parkinson's Disease patients and healthy subjects in China and Germany: A study of cross-cultural adaptation of the Sniffin' Sticks 12-identification test.
    PLoS One. 2019;14:e0224331.
    PubMed     Abstract available


  67. KALILANI L, Friesen D, Boudiaf N, Asgharnejad M, et al
    The characteristics and treatment patterns of patients with Parkinson's disease in the United States and United Kingdom: A retrospective cohort study.
    PLoS One. 2019;14:e0225723.
    PubMed     Abstract available


  68. MAEGAWA H, Adachi N, Hanamoto H, Kudo C, et al
    Bilateral Parkinson's disease model rats exhibit hyperalgesia to subcutaneous formalin administration into the vibrissa pad.
    PLoS One. 2019;14:e0225928.
    PubMed     Abstract available


  69. CHEN F, Wu T, Luo Y, Li Z, et al
    Amnestic mild cognitive impairment in Parkinson's disease: White matter structural changes and mechanisms.
    PLoS One. 2019;14:e0226175.
    PubMed     Abstract available


  70. MARTINEZ A, Ibarra IA, Vargas R
    A quantum chemical approach representing a new perspective concerning agonist and antagonist drugs in the context of schizophrenia and Parkinson's disease.
    PLoS One. 2019;14:e0224691.
    PubMed     Abstract available


  71. READ J, Cable S, Lofqvist C, Iwarsson S, et al
    Experiences of health services and unmet care needs of people with late-stage Parkinson's in England: A qualitative study.
    PLoS One. 2019;14:e0226916.
    PubMed     Abstract available


  72. VAN DIGGELEN F, Hrle D, Apetri M, Christiansen G, et al
    Two conformationally distinct alpha-synuclein oligomers share common epitopes and the ability to impair long-term potentiation.
    PLoS One. 2019;14:e0213663.
    PubMed     Abstract available


  73. NGUYEN TAK, Djilas M, Nowacki A, Mercanzini A, et al
    Analysis of patient-specific stimulation with segmented leads in the subthalamic nucleus.
    PLoS One. 2019;14:e0217985.
    PubMed     Abstract available


  74. CALLIZOT N, Combes M, Henriques A, Poindron P, et al
    Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins.
    PLoS One. 2019;14:e0215277.
    PubMed     Abstract available


  75. OSUAGWU N, Dolle C, Tzoulis C
    Poly-ADP-ribose assisted protein localization resolves that DJ-1, but not LRRK2 or alpha-synuclein, is localized to the mitochondrial matrix.
    PLoS One. 2019;14:e0219909.
    PubMed     Abstract available


  76. RUESINK H, Reimer L, Gregersen E, Moeller A, et al
    Stabilization of alpha-synuclein oligomers using formaldehyde.
    PLoS One. 2019;14:e0216764.
    PubMed     Abstract available


  77. TSANG AR, Rajakumar N, Jog MS
    Botulinum toxin A injection into the entopeduncular nucleus improves dynamic locomotory parameters in hemiparkinsonian rats.
    PLoS One. 2019;14:e0223450.
    PubMed     Abstract available


  78. UGOLINO J, Dziki KM, Kim A, Wu JJ, et al
    Overexpression of human Atp13a2Isoform-1 protein protects cells against manganese and starvation-induced toxicity.
    PLoS One. 2019;14:e0220849.
    PubMed     Abstract available


    January 2018
  79. REKTOR I, Svatkova A, Vojtisek L, Zikmundova I, et al
    White matter alterations in Parkinson's disease with normal cognition precede grey matter atrophy.
    PLoS One. 2018;13:e0187939.
    PubMed     Abstract available


  80. SHAO YM, Ma X, Paira P, Tan A, et al
    Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson's disease treatment.
    PLoS One. 2018;13:e0188212.
    PubMed     Abstract available


  81. YONEYAMA N, Watanabe H, Kawabata K, Bagarinao E, et al
    Severe hyposmia and aberrant functional connectivity in cognitively normal Parkinson's disease.
    PLoS One. 2018;13:e0190072.
    PubMed     Abstract available


  82. BAILLE G, Perez T, Devos D, Deken V, et al
    Early occurrence of inspiratory muscle weakness in Parkinson's disease.
    PLoS One. 2018;13:e0190400.
    PubMed     Abstract available


  83. ABUR D, Lester-Smith RA, Daliri A, Lupiani AA, et al
    Sensorimotor adaptation of voice fundamental frequency in Parkinson's disease.
    PLoS One. 2018;13:e0191839.
    PubMed     Abstract available


  84. JEHANGIR N, Yu CY, Song J, Shariati MA, et al
    Slower saccadic reading in Parkinson's disease.
    PLoS One. 2018;13:e0191005.
    PubMed     Abstract available


  85. WU YH, Chen YH, Chang MH, Lin CH, et al
    Depression in Parkinson's disease: A case-control study.
    PLoS One. 2018;13:e0192050.
    PubMed     Abstract available


  86. JAZAERI SZ, Azad A, Mehdizadeh H, Habibi SA, et al
    The effects of anxiety and external attentional focus on postural control in patients with Parkinson's disease.
    PLoS One. 2018;13:e0192168.
    PubMed     Abstract available


  87. FIGURA M, Kusmierska K, Bucior E, Szlufik S, et al
    Serum amino acid profile in patients with Parkinson's disease.
    PLoS One. 2018;13:e0191670.
    PubMed     Abstract available


  88. KHAN MM, Mendes A, Chalup SK
    Evolutionary Wavelet Neural Network ensembles for breast cancer and Parkinson's disease prediction.
    PLoS One. 2018;13:e0192192.
    PubMed     Abstract available


  89. PUSHPANATHAN ME, Loftus AM, Gasson N, Thomas MG, et al
    Beyond factor analysis: Multidimensionality and the Parkinson's Disease Sleep Scale-Revised.
    PLoS One. 2018;13:e0192394.
    PubMed     Abstract available


  90. DA SILVA FC, Iop RDR, de Oliveira LC, Boll AM, et al
    Effects of physical exercise programs on cognitive function in Parkinson's disease patients: A systematic review of randomized controlled trials of the last 10 years.
    PLoS One. 2018;13:e0193113.
    PubMed     Abstract available


  91. WOOD PL, Tippireddy S, Feriante J, Woltjer RL, et al
    Augmented frontal cortex diacylglycerol levels in Parkinson's disease and Lewy Body Disease.
    PLoS One. 2018;13:e0191815.
    PubMed     Abstract available


  92. MARRONE L, Bus C, Schondorf D, Fitzgerald JC, et al
    Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease.
    PLoS One. 2018;13:e0192497.
    PubMed     Abstract available


  93. SORENSEN DM, Holemans T, van Veen S, Martin S, et al
    Parkinson disease related ATP13A2 evolved early in animal evolution.
    PLoS One. 2018;13:e0193228.
    PubMed     Abstract available


  94. LIN FY, Yang YC, Lin CL, Lee LJ, et al
    Increased risk of overactive bladder in patients with idiopathic Parkinson's disease: Insight from a nationwide population-based cohort study.
    PLoS One. 2018;13:e0193783.
    PubMed     Abstract available


  95. PRETORIUS E, Page MJ, Mbotwe S, Kell DB, et al
    Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease.
    PLoS One. 2018;13:e0192121.
    PubMed     Abstract available


  96. STAHL K, Rahmani S, Prydz A, Skauli N, et al
    Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson's disease.
    PLoS One. 2018;13:e0194896.
    PubMed     Abstract available


  97. KRIBUS-SHMIEL L, Zeilig G, Sokolovski B, Plotnik M, et al
    How many strides are required for a reliable estimation of temporal gait parameters? Implementation of a new algorithm on the phase coordination index.
    PLoS One. 2018;13:e0192049.
    PubMed     Abstract available


  98. JEHU DA, Cantu H, Hill A, Paquette C, et al
    Medication and trial duration influence postural and pointing parameters during a standing repetitive pointing task in individuals with Parkinson's disease.
    PLoS One. 2018;13:e0195322.
    PubMed     Abstract available


  99. KIM KH, Kang SY, Shin DA, Yi S, et al
    Parkinson's disease-related non-motor features as risk factors for post-operative delirium in spinal surgery.
    PLoS One. 2018;13:e0195749.
    PubMed     Abstract available


  100. YOSHIDA T, Masani K, Zabjek K, Popovic MR, et al
    Dynamic cortical participation during bilateral, cyclical ankle movements: Effects of Parkinson's disease.
    PLoS One. 2018;13:e0196177.
    PubMed     Abstract available


  101. BADEA L, Onu M, Wu T, Roceanu A, et al
    Correction: Exploring the reproducibility of functional connectivity alterations in Parkinson's disease.
    PLoS One. 2018;13:e0197121.
    PubMed     Abstract available


  102. TURCATO AM, Godi M, Giardini M, Arcolin I, et al
    Abnormal gait pattern emerges during curved trajectories in high-functioning Parkinsonian patients walking in line at normal speed.
    PLoS One. 2018;13:e0197264.
    PubMed     Abstract available


  103. SALAMA M, Shalash A, Magdy A, Makar M, et al
    Tubulin and Tau: Possible targets for diagnosis of Parkinson's and Alzheimer's diseases.
    PLoS One. 2018;13:e0196436.
    PubMed     Abstract available


  104. TEJERA-PARRADO C, Jesus S, Lopez-Ruiz A, Buiza-Rueda D, et al
    TMEM230 in Parkinson's disease in a southern Spanish population.
    PLoS One. 2018;13:e0197271.
    PubMed     Abstract available


  105. MA J, Ma S, Zou H, Zhang Y, et al
    Impaired serial ordering in nondemented patients with mild Parkinson's disease.
    PLoS One. 2018;13:e0197489.
    PubMed     Abstract available


  106. LEE HJ, Uhm JS, Hong YJ, Hur J, et al
    Altered myocardial characteristics of the preexcited segment in Wolff-Parkinson-White syndrome: A pilot study with cardiac magnetic resonance imaging.
    PLoS One. 2018;13:e0198218.
    PubMed     Abstract available


  107. KAWASHIMA S, Ueki Y, Kato T, Ito K, et al
    Reduced striatal dopamine release during motor skill acquisition in Parkinson's disease.
    PLoS One. 2018;13:e0196661.
    PubMed     Abstract available


  108. MARSHALL MS, Jakubauskas B, Bogue W, Stoskute M, et al
    Analysis of age-related changes in psychosine metabolism in the human brain.
    PLoS One. 2018;13:e0193438.
    PubMed     Abstract available


  109. TOMITA S, Oeda T, Umemura A, Kohsaka M, et al
    Video-fluoroscopic swallowing study scale for predicting aspiration pneumonia in Parkinson's disease.
    PLoS One. 2018;13:e0197608.
    PubMed     Abstract available


  110. SCHNEIDER JS
    Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.
    PLoS One. 2018;13:e0199189.
    PubMed     Abstract available


  111. JUSTE FS, Sassi FC, Costa JB, de Andrade CRF, et al
    Frequency of speech disruptions in Parkinson's Disease and developmental stuttering: A comparison among speech tasks.
    PLoS One. 2018;13:e0199054.
    PubMed     Abstract available


  112. WANG SM, Tickle-Degnen L
    Emotional cues from expressive behavior of women and men with Parkinson's disease.
    PLoS One. 2018;13:e0199886.
    PubMed     Abstract available


  113. WEI L, Zhang J, Long Z, Wu GR, et al
    Correction: Reduced Topological Efficiency in Cortical-Basal Ganglia Motor Network of Parkinson's Disease: A Resting State fMRI Study.
    PLoS One. 2018;13:e0200623.
    PubMed     Abstract available


  114. WU CH, Yang BH, Chou YH, Wang SJ, et al
    Effects of 99mTc-TRODAT-1 drug template on image quantitative analysis.
    PLoS One. 2018;13:e0194503.
    PubMed     Abstract available


  115. CHEN NK, Chang HC, Bilgin A, Bernstein A, et al
    A diffusion-matched principal component analysis (DM-PCA) based two-channel denoising procedure for high-resolution diffusion-weighted MRI.
    PLoS One. 2018;13:e0195952.
    PubMed     Abstract available


  116. SANCHEZ-LANZAS R, Castano JG
    Inhibitors of lysosomal function or serum starvation in control or LAMP2 deficient cells do not modify the cellular levels of Parkinson disease-associated DJ-1/PARK 7 protein.
    PLoS One. 2018;13:e0201152.
    PubMed     Abstract available


  117. OHMICHI T, Kasai T, Kosaka T, Shikata K, et al
    Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson's disease.
    PLoS One. 2018;13:e0201260.
    PubMed     Abstract available


  118. LASSEN LB, Gregersen E, Isager AK, Betzer C, et al
    ELISA method to detect alpha-synuclein oligomers in cell and animal models.
    PLoS One. 2018;13:e0196056.
    PubMed     Abstract available


  119. BEYLE A, Glonnegger H, Cerff B, Graber S, et al
    The Multiple Object Test as a performance-based tool to assess the decline of ADL function in Parkinson's disease.
    PLoS One. 2018;13:e0200990.
    PubMed     Abstract available


  120. CHOI MG, Kim MJ, Kim DG, Yu R, et al
    Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide.
    PLoS One. 2018;13:e0195339.
    PubMed     Abstract available


  121. LARSSON V, Torisson G, Londos E
    Relative survival in patients with dementia with Lewy bodies and Parkinson's disease dementia.
    PLoS One. 2018;13:e0202044.
    PubMed     Abstract available


  122. CHAHINE LM, Urbe L, Caspell-Garcia C, Aarsland D, et al
    Cognition among individuals along a spectrum of increased risk for Parkinson's disease.
    PLoS One. 2018;13:e0201964.
    PubMed     Abstract available


  123. KAWASAKI T, Mikami K, Kamo T, Aoki R, et al
    Motor planning error in Parkinson's disease and its clinical correlates.
    PLoS One. 2018;13:e0202228.
    PubMed     Abstract available


  124. CHOUDHURY GR, Daadi MM
    Charting the onset of Parkinson-like motor and non-motor symptoms in nonhuman primate model of Parkinson's disease.
    PLoS One. 2018;13:e0202770.
    PubMed     Abstract available


  125. LAI CY, Chiang JH, Lin JG, Yen HR, et al
    Chinese herbal medicine reduced the risk of stroke in patients with Parkinson's disease: A population-based retrospective cohort study from Taiwan.
    PLoS One. 2018;13:e0203473.
    PubMed     Abstract available


  126. PERLBARG V, Lambert J, Butler B, Felfli M, et al
    Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
    PLoS One. 2018;13:e0202597.
    PubMed     Abstract available


  127. SUPANDI F, van Beek JHGM
    Computational prediction of changes in brain metabolic fluxes during Parkinson's disease from mRNA expression.
    PLoS One. 2018;13:e0203687.
    PubMed     Abstract available


  128. LEE Y, Oh JS, Chung SJ, Lee JJ, et al
    The presence of depression in de novo Parkinson's disease reflects poor motor compensation.
    PLoS One. 2018;13:e0203303.
    PubMed     Abstract available


  129. HILLER AL, Murchison CF, Lobb BM, O'Connor S, et al
    A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson's disease: Does age matter?
    PLoS One. 2018;13:e0203637.
    PubMed     Abstract available


  130. MALLING ASB, Morberg BM, Wermuth L, Gredal O, et al
    Effect of transcranial pulsed electromagnetic fields (T-PEMF) on functional rate of force development and movement speed in persons with Parkinson's disease: A randomized clinical trial.
    PLoS One. 2018;13:e0204478.
    PubMed     Abstract available


  131. ONGUN N
    Does nutritional status affect Parkinson's Disease features and quality of life?
    PLoS One. 2018;13:e0205100.
    PubMed     Abstract available


  132. T DOS SANTOS MC, Scheller D, Schulte C, Mesa IR, et al
    Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson's disease diagnosis.
    PLoS One. 2018;13:e0206536.
    PubMed     Abstract available


  133. GARZO A, Silva PA, Garay-Vitoria N, Hernandez E, et al
    Design and development of a gait training system for Parkinson's disease.
    PLoS One. 2018;13:e0207136.
    PubMed     Abstract available


  134. DANESHZAND M, Faezipour M, Barkana BD
    Robust desynchronization of Parkinson's disease pathological oscillations by frequency modulation of delayed feedback deep brain stimulation.
    PLoS One. 2018;13:e0207761.
    PubMed     Abstract available


  135. HURTADO-POMARES M, Terol-Cantero MC, Sanchez-Perez A, Leiva-Santana C, et al
    Measuring executive dysfunction in Parkinson's disease: Reliability and validity of the Spanish version of Frontal Assessment Battery (FAB-E).
    PLoS One. 2018;13:e0207698.
    PubMed     Abstract available


  136. OUERFELLI-ETHIER J, Elsaeid B, Desgroseilliers J, Munoz DP, et al
    Anti-saccades predict cognitive functions in older adults and patients with Parkinson's disease.
    PLoS One. 2018;13:e0207589.
    PubMed     Abstract available


  137. CANTU H, Cote JN, Nantel J
    A new method based on quiet stance baseline is more effective in identifying freezing in Parkinson's disease.
    PLoS One. 2018;13:e0207945.
    PubMed     Abstract available


  138. OKUBADEJO NU, Rizig M, Ojo OO, Jonvik H, et al
    Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease.
    PLoS One. 2018;13:e0207984.
    PubMed     Abstract available


  139. HONMA M, Masaoka Y, Koyama S, Kuroda T, et al
    Impaired cognitive modification for estimating time duration in Parkinson's disease.
    PLoS One. 2018;13:e0208956.
    PubMed     Abstract available


  140. WILLKOMMEN D, Lucio M, Moritz F, Forcisi S, et al
    Metabolomic investigations in cerebrospinal fluid of Parkinson's disease.
    PLoS One. 2018;13:e0208752.
    PubMed     Abstract available


  141. SUZUKI A, Ito M, Hamaguchi T, Mori H, et al
    Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson's disease.
    PLoS One. 2018;13:e0208313.
    PubMed     Abstract available


  142. HAEGELEN C, Baumgarten C, Houvenaghel JF, Zhao Y, et al
    Functional atlases for analysis of motor and neuropsychological outcomes after medial globus pallidus and subthalamic stimulation.
    PLoS One. 2018;13:e0200262.
    PubMed     Abstract available


  143. ARNULFO G, Pozzi NG, Palmisano C, Leporini A, et al
    Phase matters: A role for the subthalamic network during gait.
    PLoS One. 2018;13:e0198691.
    PubMed     Abstract available


  144. DUCHIN Y, Shamir RR, Patriat R, Kim J, et al
    Patient-specific anatomical model for deep brain stimulation based on 7 Tesla MRI.
    PLoS One. 2018;13:e0201469.
    PubMed     Abstract available


  145. TYULMANKOV D, Tass PA, Bokil H
    Periodic flashing coordinated reset stimulation paradigm reduces sensitivity to ON and OFF period durations.
    PLoS One. 2018;13:e0203782.
    PubMed     Abstract available


  146. SHIMONY JS, Rutlin J, Karimi M, Tian L, et al
    Validation of diffusion tensor imaging measures of nigrostriatal neurons in macaques.
    PLoS One. 2018;13:e0202201.
    PubMed     Abstract available


  147. STILES L, Zheng Y, Smith PF
    The effects of electrical stimulation of the peripheral vestibular system on neurochemical release in the rat striatum.
    PLoS One. 2018;13:e0205869.
    PubMed     Abstract available


  148. LIN W, Xie YC, Cheng PY, Dong LY, et al
    Association of visual hallucinations with very mild degenerative dementia due to dementia with Lewy bodies.
    PLoS One. 2018;13:e0205909.
    PubMed     Abstract available


  149. KLYUZHIN IS, Fu JF, Hong A, Sacheli M, et al
    Data-driven, voxel-based analysis of brain PET images: Application of PCA and LASSO methods to visualize and quantify patterns of neurodegeneration.
    PLoS One. 2018;13:e0206607.
    PubMed     Abstract available


    January 2017
  150. TRENADO C, Elben S, Friggemann L, Gruhn S, et al
    Long-Latency Somatosensory Evoked Potentials of the Subthalamic Nucleus in Patients with Parkinson's Disease.
    PLoS One. 2017;12:e0168151.
    PubMed     Abstract available


  151. RICCIARDI L, Visco-Comandini F, Erro R, Morgante F, et al
    Facial Emotion Recognition and Expression in Parkinson's Disease: An Emotional Mirror Mechanism?
    PLoS One. 2017;12:e0169110.
    PubMed     Abstract available


  152. JING H, Wang S, Wang M, Fu W, et al
    Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-kappaB Pathway.
    PLoS One. 2017;12:e0169560.
    PubMed     Abstract available


  153. YAMAMOTO T, Asahina M, Yamanaka Y, Uchiyama T, et al
    The Utility of Post-Void Residual Volume versus Sphincter Electromyography to Distinguish between Multiple System Atrophy and Parkinson's Disease.
    PLoS One. 2017;12:e0169405.
    PubMed     Abstract available


  154. STOTT SR, Hayat S, Carnwath T, Garas S, et al
    CD24 expression does not affect dopamine neuronal survival in a mouse model of Parkinson's disease.
    PLoS One. 2017;12:e0171748.
    PubMed     Abstract available


  155. ZEISS CJ, Allore HG, Beck AP
    Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson's disease.
    PLoS One. 2017;12:e0171790.
    PubMed     Abstract available


  156. PAUL R, Choudhury A, Kumar S, Giri A, et al
    Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    PLoS One. 2017;12:e0171285.
    PubMed     Abstract available


  157. CIESIELSKA A, Samaranch L, San Sebastian W, Dickson DW, et al
    Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.
    PLoS One. 2017;12:e0169965.
    PubMed     Abstract available



  158. Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-beta Generation and gamma-Secretase Activity.
    PLoS One. 2017;12:e0172775.
    PubMed     Abstract available


  159. VASTA R, Nicoletti A, Mostile G, Dibilio V, et al
    Side effects induced by the acute levodopa challenge in Parkinson's Disease and atypical parkinsonisms.
    PLoS One. 2017;12:e0172145.
    PubMed     Abstract available


  160. CHAN RB, Perotte AJ, Zhou B, Liong C, et al
    Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis.
    PLoS One. 2017;12:e0172348.
    PubMed     Abstract available


  161. NACKAERTS E, Heremans E, Smits-Engelsman BC, Broeder S, et al
    Validity and reliability of a new tool to evaluate handwriting difficulties in Parkinson's disease.
    PLoS One. 2017;12:e0173157.
    PubMed     Abstract available


  162. LU J, Li X, Wang Q, Pei G, et al
    Dopamine D2 receptor and beta-arrestin 2 mediate Amyloid-beta elevation induced by anti-parkinson's disease drugs, levodopa and piribedil, in neuronal cells.
    PLoS One. 2017;12:e0173240.
    PubMed     Abstract available


  163. WESTPHAL R, Simmons C, Mesquita MB, Wood TC, et al
    Characterization of the resting-state brain network topology in the 6-hydroxydopamine rat model of Parkinson's disease.
    PLoS One. 2017;12:e0172394.
    PubMed     Abstract available


  164. WENG CC, Chen ZA, Chao KT, Ee TW, et al
    Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
    PLoS One. 2017;12:e0173503.
    PubMed     Abstract available


  165. FUJIWARA M, Ding C, Kaunitz L, Stout JC, et al
    Optokinetic nystagmus reflects perceptual directions in the onset binocular rivalry in Parkinson's disease.
    PLoS One. 2017;12:e0173707.
    PubMed     Abstract available


  166. WEN M, Zhou B, Chen YH, Ma ZL, et al
    Serum uric acid levels in patients with Parkinson's disease: A meta-analysis.
    PLoS One. 2017;12:e0173731.
    PubMed     Abstract available


  167. HUERTAS I, Jesus S, Lojo JA, Garcia-Gomez FJ, et al
    Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.
    PLoS One. 2017;12:e0174644.
    PubMed     Abstract available


  168. YAN H, Wang J
    Quantification of motor network dynamics in Parkinson's disease by means of landscape and flux theory.
    PLoS One. 2017;12:e0174364.
    PubMed     Abstract available


  169. ROZANI V, Giladi N, El-Ad B, Gurevich T, et al
    Statin adherence and the risk of Parkinson's disease: A population-based cohort study.
    PLoS One. 2017;12:e0175054.
    PubMed     Abstract available


  170. TRENADO C, Elben S, Friggemann L, Gruhn S, et al
    Correction: Long-Latency Somatosensory Evoked Potentials of the Subthalamic Nucleus in Patients with Parkinson's Disease.
    PLoS One. 2017;12:e0175602.
    PubMed     Abstract available


  171. PATERNITI I, Campolo M, Siracusa R, Cordaro M, et al
    Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson's disease.
    PLoS One. 2017;12:e0174470.
    PubMed     Abstract available


  172. PIERCE S, Coetzee GA
    Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes.
    PLoS One. 2017;12:e0175882.
    PubMed     Abstract available


  173. HUERTAS I, Jesus S, Garcia-Gomez FJ, Lojo JA, et al
    Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease.
    PLoS One. 2017;12:e0175560.
    PubMed     Abstract available


  174. FLORES ALVES DOS SANTOS J, Tezenas du Montcel S, Gargiulo M, Behar C, et al
    Tackling psychosocial maladjustment in Parkinson's disease patients following subthalamic deep-brain stimulation: A randomised clinical trial.
    PLoS One. 2017;12:e0174512.
    PubMed     Abstract available


  175. BUTCHER NJ, Merico D, Zarrei M, Ogura L, et al
    Whole-genome sequencing suggests mechanisms for 22q11.2 deletion-associated Parkinson's disease.
    PLoS One. 2017;12:e0173944.
    PubMed     Abstract available


  176. ALKEMADE A, de Hollander G, Keuken MC, Schafer A, et al
    Comparison of T2*-weighted and QSM contrasts in Parkinson's disease to visualize the STN with MRI.
    PLoS One. 2017;12:e0176130.
    PubMed     Abstract available



  177. Correction: Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.
    PLoS One. 2017;12:e0176628.
    PubMed     Abstract available


  178. ARTZI M, Even-Sapir E, Lerman Shacham H, Thaler A, et al
    DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers.
    PLoS One. 2017;12:e0175424.
    PubMed     Abstract available


  179. ALAM MN, Garg A, Munia TTK, Fazel-Rezai R, et al
    Vertical ground reaction force marker for Parkinson's disease.
    PLoS One. 2017;12:e0175951.
    PubMed     Abstract available


  180. MOONEN AJH, Weiss PH, Wiesing M, Weidner R, et al
    An fMRI study into emotional processing in Parkinson's disease: Does increased medial prefrontal activation compensate for striatal dysfunction?
    PLoS One. 2017;12:e0177085.
    PubMed     Abstract available


  181. ANGWIN AJ, Dissanayaka NNW, McMahon KL, Silburn PA, et al
    Lexical ambiguity resolution during sentence processing in Parkinson's disease: An event-related potential study.
    PLoS One. 2017;12:e0176281.
    PubMed     Abstract available


  182. CASPELL-GARCIA C, Simuni T, Tosun-Turgut D, Wu IW, et al
    Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease.
    PLoS One. 2017;12:e0175674.
    PubMed     Abstract available


  183. BHATNAGAR M, Goel I, Roy T, Shukla SD, et al
    Complete Comparison Display (CCD) evaluation of ethanol extracts of Centella asiatica and Withania somnifera shows that they can non-synergistically ameliorate biochemical and behavioural damages in MPTP induced Parkinson's model of mice.
    PLoS One. 2017;12:e0177254.
    PubMed     Abstract available


  184. GARCIA-MARTIN E, Pablo LE, Bambo MP, Alarcia R, et al
    Comparison of peripapillary choroidal thickness between healthy subjects and patients with Parkinson's disease.
    PLoS One. 2017;12:e0177163.
    PubMed     Abstract available


  185. AKHTAR RS, Xie SX, Chen YJ, Rick J, et al
    Regional brain amyloid-beta accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia.
    PLoS One. 2017;12:e0177924.
    PubMed     Abstract available


  186. BETTECKEN K, Bernhard F, Sartor J, Hobert MA, et al
    No relevant association of kinematic gait parameters with Health-related Quality of Life in Parkinson's disease.
    PLoS One. 2017;12:e0176816.
    PubMed     Abstract available


  187. SAMOTUS O, Lee J, Jog M
    Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections.
    PLoS One. 2017;12:e0178670.
    PubMed     Abstract available


  188. HAYETE B, Wuest D, Laramie J, McDonagh P, et al
    A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's disease.
    PLoS One. 2017;12:e0178982.
    PubMed     Abstract available


  189. WANG L, Wang Z, Zhu R, Bi J, et al
    Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression.
    PLoS One. 2017;12:e0179476.
    PubMed     Abstract available


  190. TU XJ, Hwang WJ, Ma HI, Chang LH, et al
    Determinants of generic and specific health-related quality of life in patients with Parkinson's disease.
    PLoS One. 2017;12:e0178896.
    PubMed     Abstract available


  191. SHAHGHOLI L, De Jesus S, Wu SS, Pei Q, et al
    Hospitalization and rehospitalization in Parkinson disease patients: Data from the National Parkinson Foundation Centers of Excellence.
    PLoS One. 2017;12:e0180425.
    PubMed     Abstract available


  192. KIM Y, Seok JM, Park J, Kim KH, et al
    The composite autonomic symptom scale 31 is a useful screening tool for patients with Parkinsonism.
    PLoS One. 2017;12:e0180744.
    PubMed     Abstract available


  193. WU MC, Xu X, Chen SM, Tyan YS, et al
    Impact of Sjogren's syndrome on Parkinson's disease: A nationwide case-control study.
    PLoS One. 2017;12:e0175836.
    PubMed     Abstract available


  194. MIKAMI K, Shiraishi M, Kawasaki T, Kamo T, et al
    Forward flexion of trunk in Parkinson's disease patients is affected by subjective vertical position.
    PLoS One. 2017;12:e0181210.
    PubMed     Abstract available


  195. ITOH Y, Voskuhl RR
    Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease.
    PLoS One. 2017;12:e0181349.
    PubMed     Abstract available


  196. SCHWENKGRUB J, Zaremba M, Joniec-Maciejak I, Cudna A, et al
    The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson's disease.
    PLoS One. 2017;12:e0182019.
    PubMed     Abstract available


  197. WU PL, Lee M, Huang TT
    Effectiveness of physical activity on patients with depression and Parkinson's disease: A systematic review.
    PLoS One. 2017;12:e0181515.
    PubMed     Abstract available


  198. NAPOLITANO F, Booth Warren E, Migliarini S, Punzo D, et al
    Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques.
    PLoS One. 2017;12:e0181677.
    PubMed     Abstract available


  199. MODO M, Crum WR, Gerwig M, Vernon AC, et al
    Magnetic resonance imaging and tensor-based morphometry in the MPTP non-human primate model of Parkinson's disease.
    PLoS One. 2017;12:e0180733.
    PubMed     Abstract available


  200. LOPEZ A, Ortiz F, Doerrier C, Venegas C, et al
    Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases.
    PLoS One. 2017;12:e0183090.
    PubMed     Abstract available


  201. ERDOGDU SAKAR B, Serbes G, Sakar CO
    Analyzing the effectiveness of vocal features in early telediagnosis of Parkinson's disease.
    PLoS One. 2017;12:e0182428.
    PubMed     Abstract available


  202. KIM HW, Oh M, Oh JS, Oh SJ, et al
    Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET.
    PLoS One. 2017;12:e0169928.
    PubMed     Abstract available


  203. VELARDE OM, Mato G, Dellavale D
    Mechanisms for pattern specificity of deep-brain stimulation in Parkinson's disease.
    PLoS One. 2017;12:e0182884.
    PubMed     Abstract available


  204. CHEN CY, Hung HJ, Chang KH, Hsu CY, et al
    Long-term exposure to air pollution and the incidence of Parkinson's disease: A nested case-control study.
    PLoS One. 2017;12:e0182834.
    PubMed     Abstract available


  205. BARRANTES S, Sanchez Egea AJ, Gonzalez Rojas HA, Marti MJ, et al
    Differential diagnosis between Parkinson's disease and essential tremor using the smartphone's accelerometer.
    PLoS One. 2017;12:e0183843.
    PubMed     Abstract available


  206. GAUVIN HS, Mertens J, Marien P, Santens P, et al
    Verbal monitoring in Parkinson's disease: A comparison between internal and external monitoring.
    PLoS One. 2017;12:e0182159.
    PubMed     Abstract available


  207. DALE ML, Horak FB, Wright WG, Schoneburg BM, et al
    Impaired perception of surface tilt in progressive supranuclear palsy.
    PLoS One. 2017;12:e0173351.
    PubMed     Abstract available


  208. KARAMINTZIOU SD, Custodio AL, Piallat B, Polosan M, et al
    Algorithmic design of a noise-resistant and efficient closed-loop deep brain stimulation system: A computational approach.
    PLoS One. 2017;12:e0171458.
    PubMed     Abstract available


  209. POKRZYWA M, Pawelek K, Kucia WE, Sarbak S, et al
    Effects of small-molecule amyloid modulators on a Drosophila model of Parkinson's disease.
    PLoS One. 2017;12:e0184117.
    PubMed     Abstract available


  210. LI T, Li W, Yang Y, Zhang W, et al
    Classification of brain disease in magnetic resonance images using two-stage local feature fusion.
    PLoS One. 2017;12:e0171749.
    PubMed     Abstract available


  211. RODRIGUEZ-MARTIN D, Sama A, Perez-Lopez C, Catala A, et al
    Home detection of freezing of gait using support vector machines through a single waist-worn triaxial accelerometer.
    PLoS One. 2017;12:e0171764.
    PubMed     Abstract available


  212. PEPPOLONI L, Lawrence EL, Ruffaldi E, Valero-Cuevas FJ, et al
    Characterization of the disruption of neural control strategies for dynamic fingertip forces from attractor reconstruction.
    PLoS One. 2017;12:e0172025.
    PubMed     Abstract available


  213. DELVAL A, Defebvre L, Tard C
    Freezing during tapping tasks in patients with advanced Parkinson's disease and freezing of gait.
    PLoS One. 2017;12:e0181973.
    PubMed     Abstract available


  214. GEORGIOU A, Demetriou CA, Heraclides A, Christou YP, et al
    Mitochondrial superclusters influence age of onset of Parkinson's disease in a gender specific manner in the Cypriot population: A case-control study.
    PLoS One. 2017;12:e0183444.
    PubMed     Abstract available


  215. HUO Z, Luo X, Zhan X, Chu Q, et al
    Genetic analysis of indel markers in three loci associated with Parkinson's disease.
    PLoS One. 2017;12:e0184269.
    PubMed     Abstract available


  216. SIMIELI L, Gobbi LTB, Orcioli-Silva D, Beretta VS, et al
    The variability of the steps preceding obstacle avoidance (approach phase) is dependent on the height of the obstacle in people with Parkinson's disease.
    PLoS One. 2017;12:e0184134.
    PubMed     Abstract available


  217. ZHU H, Lemos H, Bhatt B, Islam BN, et al
    Carbidopa, a drug in use for management of Parkinson disease inhibits T cell activation and autoimmunity.
    PLoS One. 2017;12:e0183484.
    PubMed     Abstract available


  218. TUGAEVA KV, Tsvetkov PO, Sluchanko NN
    Bacterial co-expression of human Tau protein with protein kinase A and 14-3-3 for studies of 14-3-3/phospho-Tau interaction.
    PLoS One. 2017;12:e0178933.
    PubMed     Abstract available


  219. RASSU M, Del Giudice MG, Sanna S, Taymans JM, et al
    Role of LRRK2 in the regulation of dopamine receptor trafficking.
    PLoS One. 2017;12:e0179082.
    PubMed     Abstract available


  220. MABROUK R, Strafella AP, Knezevic D, Ghadery C, et al
    Feasibility study of TSPO quantification with [18F]FEPPA using population-based input function.
    PLoS One. 2017;12:e0177785.
    PubMed     Abstract available


  221. SHRESTHA S, Kamel F, Umbach DM, Beane Freeman LE, et al
    Nonmotor symptoms and Parkinson disease in United States farmers and spouses.
    PLoS One. 2017;12:e0185510.
    PubMed     Abstract available


  222. HUANG SL, Hsieh CL, Wu RM, Lu WS, et al
    Test-retest reliability and minimal detectable change of the Beck Depression Inventory and the Taiwan Geriatric Depression Scale in patients with Parkinson's disease.
    PLoS One. 2017;12:e0184823.
    PubMed     Abstract available


  223. BEN EL HAJ R, Salmi A, Regragui W, Moussa A, et al
    Evidence for prehistoric origins of the G2019S mutation in the North African Berber population.
    PLoS One. 2017;12:e0181335.
    PubMed     Abstract available


  224. YANG Y, Qin M, Bao P, Xu W, et al
    Secretory carrier membrane protein 5 is an autophagy inhibitor that promotes the secretion of alpha-synuclein via exosome.
    PLoS One. 2017;12:e0180892.
    PubMed     Abstract available


  225. NACHEVA E, Mokretar K, Soenmez A, Pittman AM, et al
    DNA isolation protocol effects on nuclear DNA analysis by microarrays, droplet digital PCR, and whole genome sequencing, and on mitochondrial DNA copy number estimation.
    PLoS One. 2017;12:e0180467.
    PubMed     Abstract available


  226. VAICIUKYNAS E, Verikas A, Gelzinis A, Bacauskiene M, et al
    Detecting Parkinson's disease from sustained phonation and speech signals.
    PLoS One. 2017;12:e0185613.
    PubMed     Abstract available


  227. DOUCET M, El-Turabi A, Zabel F, Hunn BHM, et al
    Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles.
    PLoS One. 2017;12:e0181844.
    PubMed     Abstract available


  228. SCHLACHETZKI JCM, Barth J, Marxreiter F, Gossler J, et al
    Wearable sensors objectively measure gait parameters in Parkinson's disease.
    PLoS One. 2017;12:e0183989.
    PubMed     Abstract available


  229. GRAMSCH C, Reuter I, Kraff O, Quick HH, et al
    Nigrosome 1 visibility at susceptibility weighted 7T MRI-A dependable diagnostic marker for Parkinson's disease or merely an inconsistent, age-dependent imaging finding?
    PLoS One. 2017;12:e0185489.
    PubMed     Abstract available


  230. MIJALKOV M, Kakaei E, Pereira JB, Westman E, et al
    BRAPH: A graph theory software for the analysis of brain connectivity.
    PLoS One. 2017;12:e0178798.
    PubMed     Abstract available


  231. MORALES I, Sanchez A, Rodriguez-Sabate C, Rodriguez M, et al
    Striatal astrocytes engulf dopaminergic debris in Parkinson's disease: A study in an animal model.
    PLoS One. 2017;12:e0185989.
    PubMed     Abstract available


  232. ZONDLER L, Kostka M, Garidel P, Heinzelmann U, et al
    Proteasome impairment by alpha-synuclein.
    PLoS One. 2017;12:e0184040.
    PubMed     Abstract available


  233. MATSUI H, Sugie A
    An optimized method for counting dopaminergic neurons in zebrafish.
    PLoS One. 2017;12:e0184363.
    PubMed     Abstract available


  234. PICILLO M, Pivonello R, Santangelo G, Pivonello C, et al
    Serum IGF-1 is associated with cognitive functions in early, drug-naive Parkinson's disease.
    PLoS One. 2017;12:e0186508.
    PubMed     Abstract available


  235. PARK HJ, Ryu D, Parmar M, Giasson BI, et al
    The ER retention protein RER1 promotes alpha-synuclein degradation via the proteasome.
    PLoS One. 2017;12:e0184262.
    PubMed     Abstract available


  236. PERJU-DUMBRAVA L, Lau K, Phyland D, Papanikolaou V, et al
    Arytenoid cartilage movements are hypokinetic in Parkinson's disease: A quantitative dynamic computerised tomographic study.
    PLoS One. 2017;12:e0186611.
    PubMed     Abstract available


  237. MINATO T, Maeda T, Fujisawa Y, Tsuji H, et al
    Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study.
    PLoS One. 2017;12:e0187307.
    PubMed     Abstract available


  238. MORISHITA T, Hilliard JD, Okun MS, Neal D, et al
    Postoperative lead migration in deep brain stimulation surgery: Incidence, risk factors, and clinical impact.
    PLoS One. 2017;12:e0183711.
    PubMed     Abstract available


  239. UCHINO K, Shiraishi M, Tanaka K, Akamatsu M, et al
    Impact of inability to turn in bed assessed by a wearable three-axis accelerometer on patients with Parkinson's disease.
    PLoS One. 2017;12:e0187616.
    PubMed     Abstract available


  240. ADAMS WR
    High-accuracy detection of early Parkinson's Disease using multiple characteristics of finger movement while typing.
    PLoS One. 2017;12:e0188226.
    PubMed     Abstract available


  241. BADEA L, Onu M, Wu T, Roceanu A, et al
    Exploring the reproducibility of functional connectivity alterations in Parkinson's disease.
    PLoS One. 2017;12:e0188196.
    PubMed     Abstract available


  242. NICOLETTI A, Mostile G, Stocchi F, Abbruzzese G, et al
    Factors influencing psychological well-being in patients with Parkinson's disease.
    PLoS One. 2017;12:e0189682.
    PubMed     Abstract available


  243. GODINO-LLORENTE JI, Shattuck-Hufnagel S, Choi JY, Moro-Velazquez L, et al
    Towards the identification of Idiopathic Parkinson's Disease from the speech. New articulatory kinetic biomarkers.
    PLoS One. 2017;12:e0189583.
    PubMed     Abstract available


  244. BAJAJ S, Krismer F, Palma JA, Wenning GK, et al
    Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0189897.
    PubMed     Abstract available


  245. PINHO R, Guedes LC, Soreq L, Lobo PP, et al
    Correction: Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles.
    PLoS One. 2017;12:e0190552.
    PubMed     Abstract available


  246. ZHOU W, Barkow JC, Freed CR
    Running wheel exercise reduces alpha-synuclein aggregation and improves motor and cognitive function in a transgenic mouse model of Parkinson's disease.
    PLoS One. 2017;12:e0190160.
    PubMed     Abstract available


  247. NACKAERTS E, Broeder S, Pereira MP, Swinnen SP, et al
    Handwriting training in Parkinson's disease: A trade-off between size, speed and fluency.
    PLoS One. 2017;12:e0190223.
    PubMed     Abstract available


  248. SILVA DE LIMA AL, Hahn T, Evers LJW, de Vries NM, et al
    Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease.
    PLoS One. 2017;12:e0189161.
    PubMed     Abstract available


  249. BARGIOTAS P, Eugster L, Oberholzer M, Debove I, et al
    Sleep-wake functions and quality of life in patients with subthalamic deep brain stimulation for Parkinson's disease.
    PLoS One. 2017;12:e0190027.
    PubMed     Abstract available


    January 2016
  250. YUAN J, Ren J, Wang Y, He X, et al
    Acteoside Binds to Caspase-3 and Exerts Neuroprotection in the Rotenone Rat Model of Parkinson's Disease.
    PLoS One. 2016;11:e0162696.
    PubMed     Abstract available


  251. MUN JK, Youn J, Cho JW, Oh ES, et al
    Weight Change Is a Characteristic Non-Motor Symptom in Drug-Naive Parkinson's Disease Patients with Non-Tremor Dominant Subtype: A Nation-Wide Observational Study.
    PLoS One. 2016;11:e0162254.
    PubMed     Abstract available


  252. YANG W, Liu B, Huang B, Huang R, et al
    Altered Resting-State Functional Connectivity of the Striatum in Parkinson's Disease after Levodopa Administration.
    PLoS One. 2016;11:e0161935.
    PubMed     Abstract available


  253. MARIANI E, Frabetti F, Tarozzi A, Pelleri MC, et al
    Meta-Analysis of Parkinson's Disease Transcriptome Data Using TRAM Software: Whole Substantia Nigra Tissue and Single Dopamine Neuron Differential Gene Expression.
    PLoS One. 2016;11:e0161567.
    PubMed     Abstract available


  254. ZHANG X, Ye YL, Zhu H, Sun SN, et al
    Selenotranscriptomic Analyses Identify Signature Selenoproteins in Brain Regions in a Mouse Model of Parkinson's Disease.
    PLoS One. 2016;11:e0163372.
    PubMed     Abstract available


  255. MOREAU C, Devos D, Baille G, Delval A, et al
    Are Upper-Body Axial Symptoms a Feature of Early Parkinson's Disease?
    PLoS One. 2016;11:e0162904.
    PubMed     Abstract available


  256. ALMEIDA OP, McCaul K, Hankey GJ, Yeap BB, et al
    Affective Disorders, Psychosis and Dementia in a Community Sample of Older Men with and without Parkinson's Disease.
    PLoS One. 2016;11:e0163781.
    PubMed     Abstract available


  257. DEWEY RB 3RD, O'Suilleabhain PE, Sanghera M, Patel N, et al
    Developing a Deep Brain Stimulation Neuromodulation Network for Parkinson Disease, Essential Tremor, and Dystonia: Report of a Quality Improvement Project.
    PLoS One. 2016;11:e0164154.
    PubMed     Abstract available


  258. DEAN DC 3RD, Sojkova J, Hurley S, Kecskemeti S, et al
    Alterations of Myelin Content in Parkinson's Disease: A Cross-Sectional Neuroimaging Study.
    PLoS One. 2016;11:e0163774.
    PubMed     Abstract available


  259. WANG S, Zhang S, Xu C, Barron A, et al
    Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson's Disease.
    PLoS One. 2016;11:e0164465.
    PubMed     Abstract available


  260. SAN LUCIANO M, Wang C, Ortega RA, Yu Q, et al
    Digitized Spiral Drawing: A Possible Biomarker for Early Parkinson's Disease.
    PLoS One. 2016;11:e0162799.
    PubMed     Abstract available


  261. GAO R, Zhang G, Chen X, Yang A, et al
    CSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson's Disease-A Preliminary Report.
    PLoS One. 2016;11:e0164762.
    PubMed     Abstract available


  262. YE R, Shen T, Jiang Y, Xu L, et al
    The Relationship between Parkinson Disease and Brain Tumor: A Meta-Analysis.
    PLoS One. 2016;11:e0164388.
    PubMed     Abstract available


  263. KIM D, Jeon H, Ryu S, Koo S, et al
    Proteomic Analysis of the Effect of Korean Red Ginseng in the Striatum of a Parkinson's Disease Mouse Model.
    PLoS One. 2016;11:e0164906.
    PubMed     Abstract available


  264. MAKOVAC E, Cercignani M, Serra L, Torso M, et al
    Brain Connectivity Changes in Autosomal Recessive Parkinson Disease: A Model for the Sporadic Form.
    PLoS One. 2016;11:e0163980.
    PubMed     Abstract available


  265. LOVEREIDE L, Hagell P
    Measuring Life Satisfaction in Parkinson's Disease and Healthy Controls Using the Satisfaction With Life Scale.
    PLoS One. 2016;11:e0163931.
    PubMed     Abstract available


  266. PETSCHOW C, Scheef L, Paus S, Zimmermann N, et al
    Central Pain Processing in Early-Stage Parkinson's Disease: A Laser Pain fMRI Study.
    PLoS One. 2016;11:e0164607.
    PubMed     Abstract available


  267. FUJITA H, Suzuki K, Numao A, Watanabe Y, et al
    Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    PLoS One. 2016;11:e0165869.
    PubMed     Abstract available


  268. KRONIMUS Y, Albus A, Balzer-Geldsetzer M, Straub S, et al
    Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.
    PLoS One. 2016;11:e0164953.
    PubMed     Abstract available


  269. ZHANG Y, Wu IW, Tosun D, Foster E, et al
    Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.
    PLoS One. 2016;11:e0165540.
    PubMed     Abstract available


  270. JAVOR A, Ransmayr G, Struhal W, Riedl R, et al
    Parkinson Patients' Initial Trust in Avatars: Theory and Evidence.
    PLoS One. 2016;11:e0165998.
    PubMed     Abstract available


  271. KOMNIG D, Imgrund S, Reich A, Grunder S, et al
    ASIC1a Deficient Mice Show Unaltered Neurodegeneration in the Subacute MPTP Model of Parkinson Disease.
    PLoS One. 2016;11:e0165235.
    PubMed     Abstract available


  272. LU J, Cui J, Li X, Wang X, et al
    An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-beta Generation and gamma-Secretase Activity.
    PLoS One. 2016;11:e0166415.
    PubMed     Abstract available


  273. HSU YC, Chang CW, Lee HL, Chuang CC, et al
    Association between History of Dental Amalgam Fillings and Risk of Parkinson's Disease: A Population-Based Retrospective Cohort Study in Taiwan.
    PLoS One. 2016;11:e0166552.
    PubMed     Abstract available


  274. KOPRICH JB, Johnston TH, Reyes G, Omana V, et al
    Towards a Non-Human Primate Model of Alpha-Synucleinopathy for Development of Therapeutics for Parkinson's Disease: Optimization of AAV1/2 Delivery Parameters to Drive Sustained Expression of Alpha Synuclein and Dopaminergic Degeneration in Macaque.
    PLoS One. 2016;11:e0167235.
    PubMed     Abstract available


  275. LEE MJ, Son JS, Lee JH, Kim SJ, et al
    Impact of Prolonged Temporal Discrimination Threshold on Finger Movements of Parkinson's Disease.
    PLoS One. 2016;11:e0167034.
    PubMed     Abstract available


  276. JESUS S, Huertas I, Bernal-Bernal I, Bonilla-Toribio M, et al
    GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease.
    PLoS One. 2016;11:e0167749.
    PubMed     Abstract available


  277. BRYAN L, Kaye W, Antao V, Mehta P, et al
    Preliminary Results of National Amyotrophic Lateral Sclerosis (ALS) Registry Risk Factor Survey Data.
    PLoS One. 2016;11:e0153683.
    PubMed     Abstract available


  278. KRUSE N, Schlossmacher MG, Schulz-Schaeffer WJ, Vanmechelen E, et al
    A First Tetraplex Assay for the Simultaneous Quantification of Total alpha-Synuclein, Tau, beta-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid.
    PLoS One. 2016;11:e0153564.
    PubMed     Abstract available


  279. BLOCK VA, Pitsch E, Tahir P, Cree BA, et al
    Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
    PLoS One. 2016;11:e0154335.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: